Send me a link:

*Text messaging rates may apply.

 Dow Down1.22% Nasdaq Down1.84%

Alexza Pharmaceuticals Inc. (ALXA)

-NasdaqGM
4.78 Down 0.16(3.24%) 12:06PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 47,839   4,070   5,660  
Cost of Revenue11,209   -   -  
Gross Profit 36,630   4,070   5,660  
Operating Expenses
Research Development19,082  21,849  28,262  
Selling General and Administrative15,778  11,093  11,766  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 1,770   (28,872) (34,368)
Income from Continuing Operations
Total Other Income/Expenses Net(39,887)2,320  (3,974)
Earnings Before Interest And Taxes(38,117)(26,552)(38,342)
Interest Expense1,498  1,426  2,189  
Income Before Tax(39,615)(27,978)(40,531)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(39,615)(27,978)(40,531)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (39,615) (27,978) (40,531)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (39,615) (27,978) (40,531)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.